MWMark D. Wewers

Mark D. Wewers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark D. Wewers has a total of 179 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HIV infection impairs the host response to Mycobacterium tuberculosis infection by altering surfactant protein D function in the human lung alveolar mucosa

    by Anwari Akhter, Juan I. Moliva, Abul K. Azad, Angélica Olmo-Fontánez, Andreu Garcia-Vilanova, Julia M. Scordo, Mikhail A. Gavrilin, Phillip T. Diaz, Janice J. Endsley, Susan T. Weintraub, et al.


  • Open Access

    A Pilot Cross-Sectional Study of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles for Smokers, Electronic Cigarette Users, and Never-Smokers

    by Peter G. Shields, Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Zihai Li, Joseph P. McElroy, Sarah A. Reisinger, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, et al.

    Smokers (SM) have increased lung immune cell counts and inflammatory gene expression compared to electronic cigarette (EC) users and never-smokers (NS). The objective of this study is to further assess associations for SM and EC lung microbiomes with immune cell subtypes and inflammatory gene expression in samples obtained by bronchoscopy and bronchoalveolar lavage (n = 28). RNASeq with the CIBERSORT computational algorithm were used to determine immune cell subtypes, along with inflammatory gene expression and microbiome metatranscriptomics. Macrophage subtypes revealed a two-fold increase in M0 (undifferentiated) macrophages for SM and EC users relative to NS, with a concordant decrease in M2 (anti-inflammatory) macrophages. There were 68, 19, and 1 significantly differentially expressed inflammatory genes (DEG) between SM/NS, SM/EC users, and EC users/NS, respectively. CSF-1 and GATA3 expression correlated positively and inversely with M0 and M2 macrophages, respectively. Correlation profiling for DEG showed distinct lung profiles for each participant group. There were three bacteria genera–DEG correlations and three bacteria genera–macrophage subtype correlations. In this pilot study, SM and EC use were associated with an increase in undifferentiated M0 macrophages, but SM differed from EC users and NS for inflammatory gene expression. The data support the hypothesis that SM and EC have toxic lung effects influencing inflammatory responses, but this may not be via changes in the microbiome.


  • Open Access

    Data from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    The microbiome has increasingly been linked to cancer. Little is known about the lung and oral cavity microbiomes in smokers, and even less for electronic cigarette (EC) users, compared with never-smokers. In a cross-sectional study (n = 28) of smokers, EC users, and never-smokers, bronchoalveolar lavage and saliva samples underwent metatranscriptome profiling to examine associations with lung and oral microbiomes. Pairwise comparisons assessed differentially abundant bacteria species. Total bacterial load was similar between groups, with no differences in bacterial diversity across lung microbiomes. In lungs, 44 bacteria species differed significantly (FDR < 0.1) between smokers/never-smokers, with most decreased in smokers. Twelve species differed between smokers/EC users, all decreased in smokers of which Neisseria sp. KEM232 and Curvibacter sp. AEP1-3 were observed. Among the top five decreased species in both comparisons, Neisseria elongata, Neisseria sicca, and Haemophilus parainfluenzae were observed. In the oral microbiome, 152 species were differentially abundant for smokers/never-smokers, and 17 between smokers/electronic cigarette users, but only 21 species were differentially abundant in both the lung and oral cavity. EC use is not associated with changes in the lung microbiome compared with never-smokers, indicating EC toxicity does not affect microbiota. Statistically different bacteria in smokers compared with EC users and never-smokers were almost all decreased, potentially due to toxic effects of cigarette smoke. The low numbers of overlapping oral and lung microbes suggest that the oral microbiome is not a surrogate for analyzing smoking-related effects in the lung.Prevention Relevance:The microbiome affects cancer and other disease risk. The effects of e-cig usage on the lung microbiome are essentially unknown. Given the importance of lung microbiome dysbiosis populated by oral species which have been observed to drive lung cancer progression, it is important to study effects of e-cig use on microbiome.

  • Open Access

    Supplementary Figure from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    Supplementary Figure from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

  • Open Access

    Supplementary Table from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    Supplementary Table from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

  • Open Access

    Supplementary Figure from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    Supplementary Figure from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

  • Open Access

    Supplementary Table from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    Supplementary Table from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

  • Open Access

    Data from Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    The microbiome has increasingly been linked to cancer. Little is known about the lung and oral cavity microbiomes in smokers, and even less for electronic cigarette (EC) users, compared with never-smokers. In a cross-sectional study (n = 28) of smokers, EC users, and never-smokers, bronchoalveolar lavage and saliva samples underwent metatranscriptome profiling to examine associations with lung and oral microbiomes. Pairwise comparisons assessed differentially abundant bacteria species. Total bacterial load was similar between groups, with no differences in bacterial diversity across lung microbiomes. In lungs, 44 bacteria species differed significantly (FDR < 0.1) between smokers/never-smokers, with most decreased in smokers. Twelve species differed between smokers/EC users, all decreased in smokers of which Neisseria sp. KEM232 and Curvibacter sp. AEP1-3 were observed. Among the top five decreased species in both comparisons, Neisseria elongata, Neisseria sicca, and Haemophilus parainfluenzae were observed. In the oral microbiome, 152 species were differentially abundant for smokers/never-smokers, and 17 between smokers/electronic cigarette users, but only 21 species were differentially abundant in both the lung and oral cavity. EC use is not associated with changes in the lung microbiome compared with never-smokers, indicating EC toxicity does not affect microbiota. Statistically different bacteria in smokers compared with EC users and never-smokers were almost all decreased, potentially due to toxic effects of cigarette smoke. The low numbers of overlapping oral and lung microbes suggest that the oral microbiome is not a surrogate for analyzing smoking-related effects in the lung.Prevention Relevance:The microbiome affects cancer and other disease risk. The effects of e-cig usage on the lung microbiome are essentially unknown. Given the importance of lung microbiome dysbiosis populated by oral species which have been observed to drive lung cancer progression, it is important to study effects of e-cig use on microbiome.

  • Open Access

    Saliva and Lung Microbiome Associations with Electronic Cigarette Use and Smoking

    by Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, et al.

    The microbiome has increasingly been linked to cancer. Little is known about the lung and oral cavity microbiomes in smokers, and even less for electronic cigarette (EC) users, compared with never-smokers. In a cross-sectional study (n = 28) of smokers, EC users, and never-smokers, bronchoalveolar lavage and saliva samples underwent metatranscriptome profiling to examine associations with lung and oral microbiomes. Pairwise comparisons assessed differentially abundant bacteria species. Total bacterial load was similar between groups, with no differences in bacterial diversity across lung microbiomes. In lungs, 44 bacteria species differed significantly (FDR < 0.1) between smokers/never-smokers, with most decreased in smokers. Twelve species differed between smokers/EC users, all decreased in smokers of which Neisseria sp. KEM232 and Curvibacter sp. AEP1-3 were observed. Among the top five decreased species in both comparisons, Neisseria elongata, Neisseria sicca, and Haemophilus parainfluenzae were observed. In the oral microbiome, 152 species were differentially abundant for smokers/never-smokers, and 17 between smokers/electronic cigarette users, but only 21 species were differentially abundant in both the lung and oral cavity. EC use is not associated with changes in the lung microbiome compared with never-smokers, indicating EC toxicity does not affect microbiota. Statistically different bacteria in smokers compared with EC users and never-smokers were almost all decreased, potentially due to toxic effects of cigarette smoke. The low numbers of overlapping oral and lung microbes suggest that the oral microbiome is not a surrogate for analyzing smoking-related effects in the lung. Prevention Relevance: The microbiome affects cancer and other disease risk. The effects of e-cig usage on the lung microbiome are essentially unknown. Given the importance of lung microbiome dysbiosis populated by oral species which have been observed to drive lung cancer progression, it is important to study effects of e-cig use on microbiome.